Wait a sec­ond. J&J is back in the bid­ding for Acte­lion, el­bow­ing Sanofi aside

One minute re­porters for Bloomberg and Reuters are telling you that the Sanofi $SNY takeover talks with Acte­lion $ATLN are pro­gress­ing nice­ly, and the next minute Sanofi is out and J&J is back in.

Just sev­en days af­ter J&J for­mal­ly said it was push­ing away from the deal ta­ble and drop­ping an ef­fort to buy Acte­lion, the phar­ma gi­ant now has en­tered in­to “ex­clu­sive ne­go­ti­a­tions” with the Swiss biotech.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.